Next Article in Journal
Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems
Previous Article in Journal
Engineering Cocrystals of Poorly Water-Soluble Drugs to Enhance Dissolution in Aqueous Medium
Previous Article in Special Issue
Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2018, 10(3), 109; https://doi.org/10.3390/pharmaceutics10030109

Designing of the Anticancer Nanocomposite with Sustained Release Properties by Using Graphene Oxide Nanocarrier with Phenethyl Isothiocyanate as Anticancer Agent

1
Department of Advanced Zoology and Biotechnology, Loyola Institute of Frontier Energy (LIFE), Loyola College, Chennai 600034, India
2
Material Synthesis and characterization laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang 43400, Malaysia
3
Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Malaysia
4
Henan-Macquarie Universities Joint Center for Biomedical Innovation, School of life Sciences, University of Henan Jin Ming Avenue, Kaifeng 475004, China
5
Loyola-ICAM college of engineering and Technology (LICET), Loyola Campus, Chennai 600034, India
6
Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia
7
Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia
8
Muthayammal Centre for Advanced Research, Muthayammal College of Arts and Science, Rasipuram, Namakkal, Tamilnadu 637408, India
9
Scigen Research and Innovation, Periyar Technology Business Incubator, Periyar Nagar, Thanjavur, Tamilnadu 613403, India
*
Author to whom correspondence should be addressed.
Received: 16 March 2018 / Revised: 25 April 2018 / Accepted: 25 April 2018 / Published: 1 August 2018
(This article belongs to the Special Issue Nanotechnology Advances in Cancer Treatment)
View Full-Text   |   Download PDF [1838 KB, uploaded 1 August 2018]   |  

Abstract

In this study anticancer nanocomposite was designed using graphene oxide (GO) as nanocarrier and Phenethyl isothiocyanate (PEITC) as anticancer agent. The designed formulation was characterized in detailed with XRD, Raman, UV/Vis, FTIR, DLS and TEM etc. The designed anticancer nanocomposite showed much better anticancer activity against liver cancer HepG2 cells compared to the free drug PEITC and was also found to be nontoxic to the normal 3T3 cells. In vitro release of the drug from the anticancer nanocomposite formulation was found to be sustained in human body simulated phosphate buffer saline (PBS) solution of pH 7.4 (blood pH) and pH 4.8 (intracellular lysosomal pH). This study suggests that GO could be developed as an efficient drug carrier to conjugate with PEITC for pharmaceutical applications in cancer chemotherapies. View Full-Text
Keywords: graphene oxide; anticancer; phenyisothiocyanate; nanocomposite; nano-carrier graphene oxide; anticancer; phenyisothiocyanate; nanocomposite; nano-carrier
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Jaya Seema, D.M.; Saifullah, B.; Selvanayagam, M.; Gothai, S.; Hussein, M.Z.; Subbiah, S.K.; Mohd Esa, N.; Arulselvan, P. Designing of the Anticancer Nanocomposite with Sustained Release Properties by Using Graphene Oxide Nanocarrier with Phenethyl Isothiocyanate as Anticancer Agent. Pharmaceutics 2018, 10, 109.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top